Official UK procurement notice
Tender for the Provision of a SACT Compounding and Nursing Service
Authority: Velindre University NHS Trust Please note NHS Wales Shared Services Partnership (hosted by Velindre University NHS Trust) will manage this procurement on behalf of the contracting authority. Due to having the same identifiers, we're unable to reflect this in the notice options. (Central government)
What is being bought
Published requirement descriptionA Parenteral Systemic Anti-cancer Therapy (SACT) service to be provided by a provider on behalf of Velindre Cancer Centre which is part of Velindre University NHS Trust. This service is to increase capacity in order to help meet SACT demand as required. The Medicines@Home Service, as part of the Pharmacy department at Velindre Cancer Centre, will operationally manage the service. The Medicines@Home Service has significant experience in using third party contractors for medicines homecare services including utilising third party nursing, compounders and facilities in order to provide patients with care closer to home.
- Recurrence: 2025 to 2027 dependent on extensions being exercised.
CPV: Administrative healthcare services · Supply services of nursing personnel
The lotProcurement structure
single lot · no lot value publishedLot #1The requirement is for a Parenteral Systemic Anti-cancer Therapy (SACT) service to be…Renewal
The requirement is for a Parenteral Systemic Anti-cancer Therapy (SACT) service to be provided by a provider on behalf of Velindre Cancer Centre which is part of Velindre University NHS Trust.
The purpose is to provide SACT services on behalf of Velindre Cancer Centre (a division of Velindre University NHS Trust). This includes the nursing, compounding and facility to provide a SACT service.
In recent years there has been a surge of new SACT approved by NICE / AWMSG including immunotherapy to treat solid tumour cancers. This surge is associated with significant increased demand on service resource implications: i.e. medical, nursing and pharmacy staff which is expected to continue to grow as more drugs / indications are NICE approved.
Through a process of risk assessments, some SACT have been identified as having a relatively low risk profile associated with the administration and shorter duration of infusions. Therefore, it is prudent to consider alternative models for their delivery which do not compromise patient experience and allows for treatment closer to home. Additional benefits of utilising a centralised delivery location, as opposed to individual patients’ homes, are focussed on economies of scale and service sustainability i.e. less nursing staff are required to treat the same number of patients.
The aim of this service is to increase capacity in order to help meet SACT demand as required. The Medicines@Home Service, as part of the Pharmacy department at Velindre Cancer Centre, will operationally manage the service. The Medicines@Home Service has significant experience in using third party contractors for medicines homecare services including utilising third party nursing, compounders and facilities in order to provide patients with care closer to home.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (7)
- Registration timescales from receipt of registration form: 10%
- Nursing documentation via Velindre Electronic Systems: 15%
- Minimum time required by provider between prescription being sent to provider and delivery to facility.: 20%
- Wellbeing and Future Generations Act (2015): 5%
- Foundational Economy: 5%
- price: 40%
- Carbon Footprint: 5%
Published award criteria (7)
- Registration timescales from receipt of registration form: 10%
- Nursing documentation via Velindre Electronic Systems: 15%
- Minimum time required by provider between prescription being sent to provider and delivery to facility.: 20%
- Wellbeing and Future Generations Act (2015): 5%
- Foundational Economy: 5%
- Carbon Footprint: 5%
- Price: 40%
- Staff
- Names and qualifications of delivery staff must be submitted
- Price carries 40 of 100 points: a 10% discount moves about 4 points. The method statement decides this lot, not the discount.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Closed
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Yes · 2025 to 2027 dependent on extensions being exercised.
- First published
- 4 May 2022, 15:29 BST
- Last source update
- 4 May 2022, 15:29 BST
- Award evaluation window
- 7 Jun 2022 – …
- Authority reference
VEL-VCC-FTS-43630- FTS notice number
2022/S 000-011533- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-0333aaFind a Tender
- Electronic trading
- e-invoicing allowed · electronic ordering · electronic payment
- Performance terms
Must be a member of the National Homecare Committee.
Must have MHRA Whole Sales Dealers Licence.
Facility must be provided.
Publisher note: See Tender documents NOTE: The authority is using eTenderwales to carry out this procurement process. To obtain further information record your interest on Sell2Wales at https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=120971 Under the terms of this contract the successful supplier(s) will be required to deliver Community Benefits in support of the authority’s economic and social objectives. Accordingly, contract performance conditions may relate in particular to social and environmental considerations. The Community Benefits included in this contract are: Training and recruitment of economically inactive people Supply chain initiatives and Working with the 3rd Sector Educational initiatives (WA Ref:120971)
How it was run
Official noticeTender documents are also served through a separate tool: https://etenderwales.bravosolution.co.uk/web/login.shtml ↗
- Submission deadline
- 6 Jun 2022, 12:00 BST
- Submission channel
- {"electronicSubmission"}
- Accepted languages
- en, cy
- Bid validity
- 180 days from the deadline
- Bids opened
- 7 Jun 2022, 12:00 BST
Timeline
4 May 2022 → 7 Jun 2022 · 3 dates- Notice published4 May 2022, 15:29 BST
- Submission deadline6 Jun 2022, 12:00 BST
- Bids opened7 Jun 2022, 12:00 BST
Contracting authority & participating public bodies
Dispute resolution & review bodies
- High CourtReview body
Official documents & specifications (2)
Official links; attachments are not copiedTender pack and attachments
- Economic and financial selection criteria
- Technical selection criteria